New York welfare fund files US antitrust claims against Takeda, Twi over Dexilant
MLex Summary: UFCW Local 1500 Welfare Fund filed a US complaint on behalf of end-payers, accusing Takeda Pharmaceutical and Twi Pharmaceuticals of entering into an illegal reverse payment agreement to restrain competition...To view the full article, register now.
Already a subscriber? Click here to view full article